rs8192662

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_005264.8(GFRA1):​c.253T>A​(p.Tyr85Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0303 in 1,614,030 control chromosomes in the GnomAD database, including 875 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.024 ( 56 hom., cov: 33)
Exomes 𝑓: 0.031 ( 819 hom. )

Consequence

GFRA1
NM_005264.8 missense

Scores

2
10
6

Clinical Significance

Benign criteria provided, single submitter B:4

Conservation

PhyloP100: 7.19

Publications

12 publications found
Variant links:
Genes affected
GFRA1 (HGNC:4243): (GDNF family receptor alpha 1) This gene encodes a member of the glial cell line-derived neurotrophic factor receptor (GDNFR) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature receptor. Glial cell line-derived neurotrophic factor (GDNF) and neurturin (NTN) are two structurally related, potent neurotrophic factors that play key roles in the control of neuron survival and differentiation. This receptor is a glycosylphosphatidylinositol (GPI)-linked cell surface receptor for both GDNF and NTN, and mediates activation of the RET tyrosine kinase receptor. This gene is a candidate gene for Hirschsprung disease. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
GFRA1 Gene-Disease associations (from GenCC):
  • renal hypodysplasia/aplasia 4
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008683264).
BP6
Variant 10-116270903-A-T is Benign according to our data. Variant chr10-116270903-A-T is described in ClinVar as Benign. ClinVar VariationId is 1328035.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0239 (3647/152336) while in subpopulation SAS AF = 0.0366 (177/4832). AF 95% confidence interval is 0.0322. There are 56 homozygotes in GnomAd4. There are 1886 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 56 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GFRA1NM_005264.8 linkc.253T>A p.Tyr85Asn missense_variant Exon 3 of 11 ENST00000355422.11 NP_005255.1 P56159-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GFRA1ENST00000355422.11 linkc.253T>A p.Tyr85Asn missense_variant Exon 3 of 11 5 NM_005264.8 ENSP00000347591.6 P56159-1

Frequencies

GnomAD3 genomes
AF:
0.0240
AC:
3649
AN:
152218
Hom.:
56
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00620
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0286
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0364
Gnomad FIN
AF:
0.0493
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0311
Gnomad OTH
AF:
0.0205
GnomAD2 exomes
AF:
0.0274
AC:
6889
AN:
251248
AF XY:
0.0292
show subpopulations
Gnomad AFR exome
AF:
0.00560
Gnomad AMR exome
AF:
0.0175
Gnomad ASJ exome
AF:
0.0200
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.0514
Gnomad NFE exome
AF:
0.0303
Gnomad OTH exome
AF:
0.0280
GnomAD4 exome
AF:
0.0310
AC:
45270
AN:
1461694
Hom.:
819
Cov.:
33
AF XY:
0.0314
AC XY:
22805
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.00526
AC:
176
AN:
33476
American (AMR)
AF:
0.0187
AC:
836
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0193
AC:
504
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0414
AC:
3568
AN:
86256
European-Finnish (FIN)
AF:
0.0458
AC:
2443
AN:
53284
Middle Eastern (MID)
AF:
0.0284
AC:
164
AN:
5768
European-Non Finnish (NFE)
AF:
0.0322
AC:
35754
AN:
1111956
Other (OTH)
AF:
0.0301
AC:
1820
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
2822
5643
8465
11286
14108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1368
2736
4104
5472
6840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0239
AC:
3647
AN:
152336
Hom.:
56
Cov.:
33
AF XY:
0.0253
AC XY:
1886
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00618
AC:
257
AN:
41596
American (AMR)
AF:
0.0286
AC:
438
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0245
AC:
85
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.0366
AC:
177
AN:
4832
European-Finnish (FIN)
AF:
0.0493
AC:
524
AN:
10624
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0311
AC:
2118
AN:
68022
Other (OTH)
AF:
0.0198
AC:
42
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
190
380
570
760
950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0280
Hom.:
30
Bravo
AF:
0.0205
TwinsUK
AF:
0.0345
AC:
128
ALSPAC
AF:
0.0361
AC:
139
ESP6500AA
AF:
0.00794
AC:
35
ESP6500EA
AF:
0.0324
AC:
279
ExAC
AF:
0.0273
AC:
3316
Asia WGS
AF:
0.00924
AC:
32
AN:
3478
EpiCase
AF:
0.0319
EpiControl
AF:
0.0327

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

GFRA1-related disorder Benign:1
May 31, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.23
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.49
.;.;T;T
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.97
.;D;.;D
MetaRNN
Benign
0.0087
T;T;T;T
MetaSVM
Benign
-0.75
T
MutationAssessor
Benign
1.9
M;M;M;M
PhyloP100
7.2
PrimateAI
Pathogenic
0.85
D
PROVEAN
Pathogenic
-5.8
D;D;D;D
REVEL
Uncertain
0.32
Sift
Uncertain
0.0040
D;D;D;D
Sift4G
Uncertain
0.011
D;D;D;D
Polyphen
0.55
P;P;P;P
Vest4
0.27
MPC
1.3
ClinPred
0.044
T
GERP RS
4.0
Varity_R
0.78
gMVP
0.77
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8192662; hg19: chr10-118030415; API